964-52-3
Chemical Structure
Moxisylyte hydrochloride
Synonym(s): Thymoxamine hydrochloride
- CAS No.: 964-52-3
- Formula:C16H26ClNO3
- Molecular Weight:315.84
IUPAC Name: 4-(2-(dimethylamino)ethoxy)-5-isopropyl-2-methylphenyl acetate hydrochloride
InChIKey: IPWGSXZCDPTDEH-UHFFFAOYSA-N
SMILES: CC(C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1)C.[H]Cl
Biological Activity: Moxisylyte (Thymoxamine) hydrochloride is a selective α1A-adrenergic receptor antagonist. Moxisylyte hydrochloride competitively antagonizes the activation mediated by norepinephrine. Moxisylyte hydrochloride relaxes penile cavernous smooth muscle and aids erectile function. Moxisylyte hydrochloride is applicable to research related to erectile dysfunction and multiple system atrophy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Moxisylyte hydrochloride | 99.65% | Moxisylyte (Thymoxamine) hydrochloride is a selective α1A-adrenergic receptor antagonist. Moxisylyte hydrochloride competitively antagonizes the activation mediated by norepinephrine. Moxisylyte hydrochloride relaxes penile cavernous smooth muscle and aids erectile function. Moxisylyte hydrochloride is applicable to research related to erectile dysfunction and multiple system atrophy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Moxisylyte hydrochloride (Standard) | ≥98% | Moxisylyte (Thymoxamine) hydrochloride Standard is the analytical standard of Moxisylyte hydrochloride (HY-B1435). This product is intended for research and analytical applications. Moxisylyte (Thymoxamine) hydrochloride is a selective α1A-adrenergic receptor antagonist. Moxisylyte hydrochloride competitively antagonizes the activation mediated by norepinephrine. Moxisylyte hydrochloride relaxes penile cavernous smooth muscle and aids erectile function. Moxisylyte hydrochloride is applicable to research related to erectile dysfunction and multiple system atrophy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Imagawa A, et al. Effect of moxisylyte hydrochloride on isolated human penile corpus cavernosum tissue. Life Sci. 1989;44(9):619-623. [Content Brief]
- [2]. Sakakibara R, et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst. 2000 Mar 15;79(2-3):191-5. [Content Brief]
